TENDER MOMENTS

Product NDC: 68828-060
11-digit product format: 688280060
Labeler code: 68828
Product ID: 68828-060_714465bd-2186-4e99-9fb7-4eb6c509b56e
Type: HUMAN OTC DRUG
Nonproprietary name: HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE
Dosage form: LOTION
Route: TOPICAL
Labeler: JAFRA COSMETICS INTERNATIONAL
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2012-04-24
Marketing end: 0000-00-00
Substance: HOMOSALATE; OCTINOXATE; OCTISALATE; OCTOCRYLENE; TITANIUM DIOXIDE; OXYBENZONE
Active strength: 10 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL; g/100mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	68828-060		I	Inactivated by FDA		2026-10-12
excluded package	package	68828-060	68828-060-13	I	Inactivated by FDA		2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	68828-060-13	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	68828-060-13	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	68828-060-13	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	68828-060-13	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	68828-060-13	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	68828-060-13	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	68828-060-13	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	68828-060-13	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	68828-060-13	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	68828-060-13	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	68828-060-13	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	68828-060-13	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	68828-060-13	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	68828-060-13	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	68828-060-13	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	68828-060-13	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	68828-060-13	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	68828-060-13	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	68828-060-13	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	68828-060-13	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	68828-060-13	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	68828-060-13	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68828-060-13	2020-01-31	C162847	48780-1	9d75b9d0-c310-f424-e053-dadaa90a57ce	TENDER MOMENTS SPF 45

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68828-060-13	TENDER MOMENTSSPF 45	50 mL in 1 TUBE	LOTION	50		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
HOMOSALATE	ACTIVE INGREDIENT	V06SV4M95S	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTISALATE	ACTIVE INGREDIENT	4X49Y0596W	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTOCRYLENE	ACTIVE INGREDIENT	5A68WGF6WM	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
TITANIUM DIOXIDE	ACTIVE INGREDIENT	15FIX9V2JP	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
HOMOSALATE	ACTIVE MOIETY	V06SV4M95S	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTISALATE	ACTIVE MOIETY	4X49Y0596W	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OCTOCRYLENE	ACTIVE MOIETY	5A68WGF6WM	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
TITANIUM DIOXIDE	ACTIVE MOIETY	15FIX9V2JP	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
.ALPHA.-TOCOPHEROL ACETATE	INACTIVE INGREDIENT	9E8X80D2L0	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
DIETHYLENE GLYCOL ADIPATE	INACTIVE INGREDIENT	6KE5V549E0	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
DMDM HYDANTOIN	INACTIVE INGREDIENT	BYR0546TOW	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
EDETATE TRISODIUM	INACTIVE INGREDIENT	420IP921MB	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
GLYCERYL STEARATE SE	INACTIVE INGREDIENT	FCZ5MH785I	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
IODOPROPYNYL BUTYLCARBAMATE	INACTIVE INGREDIENT	603P14DHEB	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
OAT	INACTIVE INGREDIENT	Z6J799EAJK	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
PANTHENOL	INACTIVE INGREDIENT	WV9CM0O67Z	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
PEG-4 LAURATE	INACTIVE INGREDIENT	AYF4VM3N1Z	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
POVIDONE K30	INACTIVE INGREDIENT	U725QWY32X	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
SODIUM PHOSPHATE, MONOBASIC	INACTIVE INGREDIENT	3980JIH2SW	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1
XANTHAN GUM	INACTIVE INGREDIENT	TTV12P4NEE	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68828-060	TENDER MOMENTS SPF 45 (HOMOSALATE OCTINOXATE OCTISALATE OXYBENZONE TITANIUM DIOXIDE OCTOCRYLENE) LOTION [JAFRA COSMETICS INTERNATIONAL]	1	Legacy NDC, 1 package rows	20120517_537296b2-3782-4081-98b2-483e8aaf8b6e.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V06SV4M95S	HOMOSALATE	118-56-9	HOMOSALATE
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
4X49Y0596W	OCTISALATE	118-60-5	OCTISALATE
5A68WGF6WM	OCTOCRYLENE	6197-30-4	OCTOCRYLENE
15FIX9V2JP	TITANIUM DIOXIDE	13463-67-7	TITANIUM DIOXIDE
95OOS7VE0Y	OXYBENZONE	131-57-7	OXYBENZONE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
68828-060-13	68828006013	50 mL in 1 TUBE	50 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TENDER MOMENTS SPF 45	JAFRA COSMETICS INTERNATIONAL \| Jafra Manufacturing, S.A. de C.V.	2012-05-16	HUMAN OTC DRUG LABEL	1